GENERIC NAME OF THE MEDICINAL PRODUCT:
Methylphenidate HCl ER Tablet IP 18mg
Methylphenidate HCl ER Tablet IP 27mg
Methylphenidate HCl ER Tablet IP 36mg
Methylphenidate HCl ER Tablet IP 54mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each film-coated tablet contains:
Methylphenidate HCl IP………………5mg
Colours: Titanium Dioxide
b) Methylphenidate HCl ER Tablet IP 18mg
Each film-coated tablet contains:
Methylphenidate HCl IP………………18mg
Colours: Titanium Dioxide Red
c) Methylphenidate HCl ER Tablet IP 27mg
Each film-coated tablet contains:
Methylphenidate HCl IP………………27mg
Colours: Quinoline Yellow
d) Methylphenidate HCl ER Tablet IP 36mg
Each film-coated tablet contains:
Methylphenidate HCl IP………………36mg
Colours: Indigo carmine
e) Methylphenidate HCl ER Tablet IP 54mg
Each film-coated tablet contains:
Methylphenidate HCl IP………………54mg
Colours: Orange 4
THERAPEUTIC INDICATIONS:
CAUTION & WARNING:
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
SCHEDULE “H” Prescription Drug -Warning: Not to be sold by retail without the prescription of a Registered Medical Prescriber.
STORAGE & DOSAGE:
Dosage: As directed by the Physician.
Methylphenidate HCl ER Tablet 27mg Technical Specification:
| Product Name: |
Methylphenidate HCl ER Tablet IP |
| Brand Name: | Generics |
| Strength: | (5mg), (18mg), (27mg), (36mg), (54mg) |
| Dosage Form: | Tablets (Un-Coated) |
| Route of Administration: | Via oral Route |
| Packing: | 30s, 90s, 100s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Regulatory Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Antipsychotic drug, Central Nervous System, central nervous system (CNS) stimulants. |
| Indication: | This medication is used to treat attention deficit hyperactivity disorder – ADHD. It works by changing the amounts of certain natural substances in the brain. Methylphenidate belongs to a class of drugs known as stimulants. |
| Storage: | Protect form moisture at a temperature not exceeding 30˚C.Do not freeze. Keep the container tightly closed in order to protect from moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Methylphenidate HCl ER Tablet IP 5mg
- Methylphenidate HCl ER Tablet IP 18mg
- Methylphenidate HCl ER Tablet IP 27mg
- Methylphenidate HCl ER Tablet IP 36mg
- Methylphenidate HCl ER Tablet IP 54mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- a) Methylphenidate HCl ER Tablet IP 5mg
Each film-coated tablet contains:
Methylphenidate HCl IP………………5mg
Colours: Titanium Dioxide - b) Methylphenidate HCl ER Tablet IP 18mg
Each film-coated tablet contains:
Methylphenidate HCl IP………………18mg
Colours: Titanium Dioxide Red - c) Methylphenidate HCl ER Tablet IP 27mg
Each film-coated tablet contains:
Methylphenidate HCl IP………………27mg
Colours: Quinoline Yellow - d) Methylphenidate HCl ER Tablet IP 36mg
Each film-coated tablet contains:
Methylphenidate HCl IP………………36mg
Colours: Indigo carmine - e) Methylphenidate HCl ER Tablet IP 54mg
Each film-coated tablet contains:
Methylphenidate HCl IP………………54mg
Colours: Orange 4
THERAPEUTIC INDICATIONS:
- This medication is used to treat attention deficit hyperactivity disorder – ADHD. It works by changing the amounts of certain natural substances in the brain. Methylphenidate belongs to a class of drugs known as stimulants.
CAUTION & WARNING:
- CAUTION:
Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH - SCHEDULE “H” Prescription Drug -Warning: Not to be sold by retail without the prescription of a Registered Medical Prescriber.
STORAGE & DOSAGE:
- Storage: Protect form moisture at a temperature not exceeding 30˚C.Do not freeze. Keep the container tightly closed in order to protect from moisture.
- Dosage: As directed by the Physician.






